These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6705139)

  • 1. Modification of the development of N-nitrosomorpholine-induced hepatic lesions by 2-acetylaminofluorene, phenobarbital and 4,4'-diaminodiphenylmethane: a sequential histological and histochemical analysis.
    Ito N; Moore MA; Bannasch P
    Carcinogenesis; 1984 Mar; 5(3):335-42. PubMed ID: 6705139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
    Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpholine.
    Weber E; Moore MA; Bannasch P
    Carcinogenesis; 1988 Jun; 9(6):1049-54. PubMed ID: 2967125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of NNM-induced carcinogenesis in the rat liver by phenobarbital: a combined morphological and enzyme histochemical approach.
    Moore MA; Hacker HJ; Kunz HW; Bannasch P
    Carcinogenesis; 1983; 4(4):473-9. PubMed ID: 6132686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonlinearities in 2-acetylaminofluorene exposure responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver.
    Williams GM; Iatropoulos MJ; Wang CX; Jeffrey AM; Thompson S; Pittman B; Palasch M; Gebhardt R
    Toxicol Sci; 1998 Oct; 45(2):152-61. PubMed ID: 9848122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of mode of action of four hepatocarcinogens: a model-based approach.
    Groos J; Bannasch P; Schwarz M; Kopp-Schneider A
    Toxicol Sci; 2007 Oct; 99(2):446-54. PubMed ID: 17636249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the peroxisome proliferator di(2-ethylhexyl)phthalate on enzymes in rat liver and on carcinogen-induced liver altered foci in comparison to the promoter phenobarbital.
    Maruyama H; Tanaka T; Williams GM
    Toxicol Pathol; 1990; 18(2):257-67. PubMed ID: 1975953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of neoplastic development in rat liver, kidney, oesophagus and forestomach by 4,4'-diaminodiphenylmethane administration.
    Tsuda H; Ogiso T; Hasegawa R; Imaida K; Masui T; Ito N
    Carcinogenesis; 1987 May; 8(5):719-22. PubMed ID: 3581430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory interaction between initial clofibrate treatment and subsequent administration of 2-acetylaminofluorene or sodium phenobarbital on glutathione S-transferase positive lesion development.
    Mutai M; Tatematsu M; Aoki T; Wada S; Ito N
    Cancer Lett; 1990 Feb; 49(2):127-32. PubMed ID: 2306705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer activity in a medium-term multi-organ bioassay for carcinogenesis.
    Spinardi AL; Kaneno R; Rodrigues MA; Salvadori DM; Rocha NS; Barbisan LF; Ribeiro LR; de Camargo JL
    Jpn J Cancer Res; 1999 Jan; 90(1):101-7. PubMed ID: 10076572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of phenobarbital on glycogen metabolism of rat liver pretreated with N-nitrosomorpholine.
    Mayer D; Moore MA; Bannasch P
    Carcinogenesis; 1983; 4(7):931-3. PubMed ID: 6307540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine.
    Weber E; Bannasch P
    Carcinogenesis; 1994 Jun; 15(6):1227-34. PubMed ID: 8020160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of trans-4-acetylaminostilbene and 2-acetylaminofluorene at the level of tumor initiation.
    Hammerl R; Kirchner T; Neumann HG
    Chem Biol Interact; 1994 Oct; 93(1):11-28. PubMed ID: 7915206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
    LeBoeuf RA; Laishes BA; Hoekstra WG
    Cancer Res; 1985 Nov; 45(11 Pt 1):5489-95. PubMed ID: 2865004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenobarbital as a promoter in the initiation/selection process of experimental rat hepatocarcinogenesis.
    Lans M; de Gerlache J; Taper HS; Préat V; Roberfroid MB
    Carcinogenesis; 1983; 4(2):141-4. PubMed ID: 6825204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced drug resistance inhibits selection of initiated cells and cancer development.
    Rissler P; Torndal UB; Eriksson LC
    Carcinogenesis; 1997 Apr; 18(4):649-55. PubMed ID: 9111195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
    Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
    Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological alterations and DNase deficiency in phenobarbital promotion of N-nitrosomorpholine initiated rat hepatocarcinogenesis.
    Taper HS; Lans M; de Gerlache J; Fort L; Roberfroid M
    Carcinogenesis; 1983; 4(2):231-4. PubMed ID: 6825212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in levels of ADP-ribose polymers in rat liver during 2-acetylaminofluorene-induced hepatocarcinogenesis.
    Kiehlbauch CC; Kosanke SD; Ringer DP
    Carcinogenesis; 1993 Jul; 14(7):1435-40. PubMed ID: 8330362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide.
    Williams GM; Furuya K
    Carcinogenesis; 1984 Feb; 5(2):171-4. PubMed ID: 6697434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.